课题基金 / 基金详情

SBIR Phase I: Technology development and pre-clinical testing of a novel minimally invasive catheter-based blood clot-retrieval and clot-filtering device

SBIR Phase I: Technology development and pre-clinical testing of a novel minimally invasive catheter-based blood clot-retrieval and clot-filtering device
SBIR 第一阶段:新型微创导管血凝块回收和凝块过滤装置的技术开发和临床前测试
批准号:
0946099
负责人:
Vallabh Janardhan
金额:
$15.0万
依托单位:
依托单位国家:
美国
项目类别:
Standard Grant
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-01-01 至 2010-06-30

项目摘要

项目成果

Vallabh Janardhan的其他基金

相似基金

相关文献

中文摘要
翻译
这个小型企业创新研究(SBIR)第一阶段项目旨在开发业界第一个基于导管的中风治疗设备,该设备既可用作血栓提取设备,也可用作血栓过滤设备。中风是纳税人的主要经济负担,每年花费655亿美元。一名中风患者的平均终身医疗成本为140,048美元。治疗急性中风的第一步是清除血液凝块,以恢复大脑的重要血液供应。然而,现有的基于导管的疗法在清除血栓方面只显示出不大的成功,对不到三分之二的中风患者有效。此外,这些疗法可以将碎片释放到血流中,导致进一步的中风。该项目的研究目标是对一种更有效的血栓回收设备和一种可以使现有中风疗法更安全的血栓过滤设备进行临床前测试。随着全球中风负担的惊人,这项研究的更广泛影响是深远的。美国每年有78万人中风,全球每年有近2050万人中风。这一项目预计将产生重要成果。首先,这种取血器在清除血栓方面的效果将得到证实。其次,这种血栓过滤设备在防止基于导管的中风治疗过程中碎片释放方面的有效性将得到证实,从而使这些程序更安全。这一公私伙伴关系预计将通过拯救生命、创造就业机会和减轻中风给纳税人造成的经济负担,对社区产生重要的积极影响。
英文摘要
This Small Business Innovation Research (SBIR) Phase I project aims to develop the industry's first catheter-based stroke treatment device that serves both as a blood clot-retrieval as well as a clot-filtering device. Stroke is a major economic burden on the tax payer costing $65.5 billion/year. The mean lifetime healthcare cost for a stroke patient is $140,048. The first step in the treatment of acute stroke is the removal of the blood clot to restore vital blood supply to the brain. However, existing catheter-based therapies have only shown modest success in removing clots and are effective in less than two-thirds of stroke patients. In addition, these therapies can release debris into the blood stream causing further strokes. The research objective of this project is to perform pre-clinical testing of a more effective clot-retrieval device and a clot-filtering device that can make existing stroke therapies safer.The broader impacts of this research are far-reaching as the global stroke burden is staggering. Each year 780,000 strokes occur in the US and nearly 20.5 million strokes occur worldwide. This project is projected to yield important outcomes. First, the efficacy of this clot-retrieval device in removing blood clots will be confirmed. Second, the efficacy of this clot-filtering device will be confirmed in preventing release of debris during catheter-based stroke treatments thereby making these procedures safer. This public-private partnership is expected to have an important positive impact on the community by saving lives, creating jobs, and decreasing the economic burden of stroke on the tax payer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SBIR Phase I: Development of a textile-based retrievable stent for stroke that can be personalized to a patient's clot burden and retrieve long clots using torsion.
  • 批准号:
    1819491
  • 项目类别:
    Standard Grant
  • 资助金额:
    $22.17万
  • 财政年份:
    2018
  • 负责人:
    Vallabh Janardhan
  • 依托单位:
国内基金
海外基金
Baryogenesis, Dark Matter and Nanohertz Gravitational Waves from a Dark Supercooled Phase Transition
  • 批准号:
    24ZR1429700
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    YUICHIRO NAKAI
  • 依托单位:
ATLAS实验探测器Phase 2升级
  • 批准号:
    11961141014
  • 项目类别:
    国际(地区)合作与交流项目
  • 资助金额:
    3350万元
  • 批准年份:
    2019
  • 负责人:
    刘衍文
  • 依托单位:
地幔含水相Phase E的温度压力稳定区域与晶体结构研究
  • 批准号:
    41802035
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    12.0万元
  • 批准年份:
    2018
  • 负责人:
    张里
  • 依托单位:
基于数字增强干涉的Phase-OTDR高灵敏度定量测量技术研究